Mirena

DRUG13 trials

Conditions

Atypical HyperplasiaContraceptionContraceptive MethodsDisease RegressionEndometrial CancerEndometrial HyperplasiaFertility IssuesFibroid

Phase 2

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

TerminatedNCT02490774

BayerContraception

Start: 2015-06-22End: 2016-07-22Updated: 2019-06-04

A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore

NCT05492487

KK Women's and Children's HospitalDisease Regression, Endometrial Hyperplasia, Fertility Issues +1

Start: 2020-01-03End: 2023-03-31Target: 60Updated: 2022-08-08

Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium

Not yet recruitingNCT06073184

University Health Network, TorontoAtypical Hyperplasia, Endometrial Cancer

Start: 2025-08-31End: 2032-02-29Target: 71Updated: 2025-06-10

Phase 3

A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

TerminatedNCT00995150

Medicines360Contraception

Start: 2009-11-30End: 2021-10-12Updated: 2024-08-14

Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding

CompletedNCT01695902

Uteron Pharma S.A.Heavy Menstrual Bleeding

Start: 2007-12-31End: 2011-09-30Updated: 2012-09-28

Phase 4

HR-QoL and Sexuality in Mirena Inserted Contraception Users

CompletedNCT00498784

BayerContraception

Start: 2005-11-30End: 2007-10-31Updated: 2013-01-23

Unknown Phase

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

CompletedNCT01613131

University of Colorado, DenverMenopausal and Other Perimenopausal Disorders

Start: 2012-04-30End: 2014-06-30Updated: 2015-12-02

Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives

TerminatedNCT01750476

Thomas Cherpes, DVM, MDInitiation of Depo-Provera (DMPA), Initiation of Mirena (LNG-IUD), Initiation of Oral Contraception (OC)

Start: 2012-12-31End: 2013-06-30Updated: 2014-01-07

Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study

CompletedNCT02067663

University of Colorado, DenverContraception

Start: 2014-04-30End: 2015-09-30Updated: 2019-07-05

Immediate Postplacental IUD Insertion

TerminatedNCT02169869

Oregon Health and Science UniversityContraception

Start: 2014-09-30End: 2017-06-30Updated: 2019-05-01

Stress Hormones and IUDs

CompletedNCT03499379

Oregon Health and Science UniversityContraception, Mood Change

Start: 2018-04-16End: 2019-12-31Updated: 2020-01-07

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level

CompletedNCT05742503

Tanta UniversityContraceptive Methods, Progesterone

Start: 2021-03-30End: 2022-03-30Updated: 2023-02-24

Clinical and Radiological effects of Dienogest on Patients with symptomatic uterine myoma vs Levonorgestrel IUD .

Active, not recruitingPACTR202506543835976

helwan universityFibroid

Start: 2025-07-15Target: 60Updated: 2026-01-27

Journal of Assisted Reproduction and Genetics2024-08-314 citations

Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study.

2023-08-243 citations

Levonorgestrel 52-mg Intrauterine Device Efficacy and Safety After More Than 8 Years of Use

Obstetrics and Gynecology2023-04-052 citations

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

Obstetrics and Gynecology2018-12-0646 citations

Bleeding patterns for the Liletta<sup>®</sup> levonorgestrel 52 mg intrauterine system.

2018-03-2114 citations